Patient Investigational New Drug (sIND) applications in the United States SAN FRANCISCO, CA / ACCESS Newswire / September 30, ...
An FDA review of mifepristone is sparking concern over politics outweighing science, even as the agency approved a new ...
The anti-abortion movement’s patience with the Food and Drug Administration (FDA) is wearing thin following the agency’s ...
Medical journals and National Comprehensive Cancer Network guidelines rarely publish FDA-identified uncertainties about new ...
The US Food and Drug Administration is reviewing evidence about the safety and efficacy of mifepristone, one of the drugs used in medication abortion, to investigate how it can be safely dispensed, US ...
The vaccine advisory committee is scheduled to meet next week to review and make recommendations for this fall’s updated ...
Health and Human Services Secretary Robert F. Kennedy Jr. told Republican states this week that the FDA would conduct a new ...
By extending their monopoly on a drug, companies prevent generics and other competitors from driving down prices. But ...
An Omaha mom says advocacy works after the Food and Drug Administration announced approval of a "lifesaving" drug her son is taking. It comes after two FDA denials this year.
Pharma companies are collaborating to boost the power of artificial intelligence (AI) in drug discovery by allowing access to ...
Now that most abortions are chemical rather than surgical, pro-life advocates have amped up pressure on lawmakers and ...
The drug will now be produced by Evita Solutions LLC, which describes its mission as being to ‘normalize abortion’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback